Prescient Therapeutics targets rare T-cell cancer in new clinical trial, doses first patient

By Proactive Investors / May 28, 2025 / www.youtube.com / Article Link


Prescient Therapeutics Ltd CEO James McDonnell talked with Proactive about the initiation of a Phase 2A clinical trial for the ...

Recent News

Immediate trigger for crash was new Fed Chairman pick
February 02, 2026 / www.canadianminingreport.com

Gold stocks slump on metal price decline
February 02, 2026 / www.canadianminingreport.com

Is the gold market starting to turn 'irrationally exuberant'?
January 26, 2026 / www.canadianminingreport.com

Gold stocks explode up as equity markets languish
January 26, 2026 / www.canadianminingreport.com

Gold stocks outpace flat large caps
January 19, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok